SHAREHOLDERS’ EQUITY | NOTE 6 – SHAREHOLDERS’ EQUITY The Company’s authorized capital stock consists of 100,000,000 0.01 10,000,000 0.001 All shares of common stock have equal voting rights and, when validly issued and outstanding, are entitled to one non-cumulative vote per share in all matters to be voted upon by shareholders. Shares of common stock have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Company’s Board of Directors (the “Board”) out of funds legally available. In the event of a liquidation, dissolution or winding up of the affairs of the Company, the holders of common stock are entitled to share ratably in all assets remaining available for distribution to them after payment or provision for all liabilities and any preferential liquidation rights of any preferred stock then outstanding. Following is an analysis of common stock issuances during the years ended August 31, 2024 and 2023: Issuances during the fiscal year ended August 31, 2024 In October 2023, the Company issued 56,547 During the year ended August 31, 2024, the Company issued 509,017 152,845 52,833 244,599 During the year ended August 31, 2024, the holder of 50,000 11,000 0.22 Issuances during the fiscal year ended August 31, 2023 In October 2022, we issued 26,833 During the year ended August 31, 2023, the Company issued 109,711 128,167 39,503 56,547 In January 2020, the Company entered into three separate consulting agreements for total consideration of 699,999 233,333 448,000 0.64 24 699,999 87,501 no 612,498 During the year ended August 31, 2023, the holders of 110,000 38,000 0.22 0.45 Options The following table sets forth certain information as of August 31, 2024 and 2023 concerning common stock that may be issued upon the exercise of options issued under the Amended 2008 Plan and outside of the Amended 2008 Plan (all options are fully vested and exercisable at August 31, 2024 and 2023): Schedule of options Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (In Years) Aggregate Intrinsic Value Outstanding, vested and exercisable at August 31, 2022 520,000 $ 0.31 2.79 $ 693,300 Options granted 620,000 1.11 — — Options exercised (110,000 ) 0.35 — — Options cancelled/forfeited/expired -- 0.45 — — Outstanding, vested and exercisable at August 31, 2023 1,030,000 0.31 2.79 693,300 Options granted 120,000 1.97 — — Options exercised (50,000 ) 0.22 — — Options cancelled forfeited/expired (120,000 ) 0.45 — — Options vested and exercisable at August 31, 2024 920,000 $ 0.91 4.37 $ 784,476 In September 2008, the Board adopted the 2008 Stock Option Plan (the “2008 Plan”), which was approved by the Company’s shareholders and provided 2,000,000 7,000,000 During the year ended August 31, 2024, the Company granted a total of 120,000 39,075 4.00 202 0.00 5 39,075 During the year ended August 31, 2024, the holder of 50,000 11,000 0.22 During the year ended August 31, 2023, the Company granted a total of 120,000 146,928 4.00 202 0.00 5 146,928 During the year ended August 31, 2023, the Company granted a total of 500,000 637,548 5.00 194 0.00 5 637,548 Warrants Warrant activity for the years ended August 31, 2024 and 2023 was as follows: Schedule of warrants Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Life (In Years) Aggregate Intrinsic Value Outstanding and exercisable at August 31, 2022 12,000 $ 0.04 1.0 $ 23,780 Warrants granted — — — — Warrants exercised — — — — Warrants cancelled/forfeited/expired (12,000 ) 0.04 — — Outstanding and exercisable at August 31, 2023 — — — — Warrants granted — — — — Warrants exercised — — — — Warrants cancelled forfeited/expired — — — — Outstanding and exercisable at August 31, 2024 — $ — — $ — |